GlassScriptPhysician profile
Thomas P Paxton
NPI 1013975093
$1,808.04
in general payments reported to CMS, 2019-2025
19 companies · $688 in 2025
The $688 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $49.83 · 2022: $193 · 2023: $398 · 2024: $480 · 2025: $688.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,566.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,565.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $541.32 | 2022-2025 | Impella |
| Kls-Martin L.P. | $229.65 | 2023-2025 | |
| Endologix LLC | $218.17 | 2025 | Afx2 Bifurcated Endograft System, Ovation Ix Iliac Stent Graft |
| Silk Road Medical, INC. | $162.53 | 2024 | Enroute Transcarotid Neuroprotection System, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter, Enroute Transcarotid Stent |
| Edwards Lifesciences Corporation | $115.28 | 2024 | Konect Resilia |
| Cook Medical LLC | $97.93 | 2025 | Zenith Spiral-Z, Cook, Zenith Alpha |
| Lantheus Medical Imaging, INC. | $86.93 | 2022 | |
| Abbott Laboratories | $63.35 | 2023 | Epic |
| Medtronic, INC. | $54.72 | 2021-2024 | Cobalt Dr Mri Surescan, Corevalve Evolut R |
| Boston Scientific Corporation | $41.29 | 2025 | General - Therapies |
| Getinge USA Sales, LLC | $36.07 | 2021 | |
| Novartis Pharmaceuticals Corporation | $30.67 | 2025 | |
| Merck Sharp & Dohme LLC | $29.11 | 2025 | Keytruda |
| Daiichi Sankyo INC. | $21.75 | 2025 | Injectafer |
| Janssen Pharmaceuticals, INC | $18.96 | 2024 | Xarelto |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $16.82 | 2025 | Clottriever Bold Catheter |
| Solventum Corporation | $16.58 | 2025 | Promogran Prisma, Activ.A.C. |
| Hydrofera LLC | $16.55 | 2025 | Hydrofera Blue |
| Cvrx, INC. | $10.36 | 2024 | Barostim Neo System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Paxton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.